For decades, the medical and public health establishment has dismissed inconvenient truths until overwhelming evidence forces acknowledgment. In the 1950s and 1960s, early warnings that smoking caused cancer were ridiculed, marginalised, and ignored. Today, we may be witnessing a similar story with a new pattern of unusually aggressive cancers, now increasingly labelled "turbo cancers."
These cancers are not ordinary. They are marked by rapid progression, sudden relapse in patients previously in remission, and the appearance of aggressive malignancies in younger individuals, cases that defy expected patterns. Yet mainstream journals, health authorities, and media outlets continue to insist that there is "no evidence," ignoring both mounting anecdotal reports and plausible biological mechanisms.
Laboratory and early clinical data suggest the spike protein delivered by mRNA vaccines could, in principle, accelerate tumour growth through immune suppression, and other means. Even if these pathways remain incompletely studied in humans, dismissing clinical observations solely because the phenomenon lacks a formal name is exactly the type of institutional inertia that historically delayed recognition of smoking-related cancers.
The evidence is already accumulating; clusters of unusually aggressive cancers, early relapses, and new onset in younger populations are being observed worldwide. Epidemiological signals, though not yet fully quantified, are consistent enough to demand urgent scrutiny. Waiting for decades of perfect data while more patients suffer, is no longer acceptable.
It is time for independent, large-scale studies, urgent reporting of aggressive cancer cases, and transparent investigation of potential causal pathways. The medical establishment cannot repeat the errors of the past by dismissing these phenomena out of hand. "Turbo cancers" may represent a new, emerging public health crisis, and ignoring them could cost countless lives.
History teaches one lesson clearly: when evidence is inconvenient, denial is never a solution. The same rigour applied to early warnings about smoking, must now be applied to turbo cancers. Of course, there will be the same resistance displayed by Big Pharma as Big Ciggy.
https://www.thefocalpoints.com/p/first-peer-reviewed-paper-defines
"Now, for the first time, a peer-reviewed scientific article titled, COVID-19 mRNA-Induced "Turbo Cancers", has been published in the Journal of Independent Medicine that formally defines "turbo cancer" and compiles the growing body of clinical cases, epidemiological signals, and mechanistic pathways explaining how COVID-19 mRNA shots and the spike protein may drive sudden, aggressive, treatment-resistant cancers:
Turbo Cancers Defined
Turbo cancers are defined as unusually aggressive, rapidly progressing malignancies.
They are marked by sudden relapses in patients previously in remission and new onset in younger individuals at advanced stages.
Epidemiological Red Flags
Data from the US, UK, and Japan show abrupt increases in cancer incidence and mortality beginning in 2021, tracking with mass vaccination campaigns.
VAERS analysis reveals the most disproportionate reports involve appendix, breast, colorectal, endometrial, laryngeal, and liver cancers.
Mechanistic Pathways Identified
The SARS-CoV-2 spike protein disrupts fundamental cancer defense systems, including:
Metabolic reprogramming (forcing cells into cancer-like energy production).
Apoptosis resistance (interfering with p53 and BRCA1 tumor suppressors).
Cancer stem cell activation (via Wnt, Notch, NF-κB, and estrogen receptor pathways).
Angiogenesis and metastasis (through VEGF, MMP9, and Galectin-3 mimicry).
Immune evasion (IgG4 induction, lymphopenia, NK-cell suppression).
Hidden Oncogenic Risks in the Shots
EBV reactivation following boosters.
SV40 DNA promoter sequences detected in vaccine vials.
N1-methyl-pseudouridine (m1Ψ) shown to accelerate tumor growth in models.
Possible reverse transcription and genomic integration of mRNA.
High-Risk Populations
Cancer survivors in remission.
Individuals with strong family history of malignancy.
The elderly (75+).
Those receiving multiple booster doses.
Proposed Preventive Approach
Authors recommend the ROOT4 protocol: EGCG (green tea extract), curcumin, vitamin D, and omega-3 fatty acids — as a low-cost, safe cancer prophylaxis for high-risk individuals.
As the authors conclude:
The emergence of turbo cancers following COVID- 19 vaccination—marked by unusually aggressive behavior, relapse in remission cases, and occurrence in younger individuals—represents a concerning clinical pattern that warrants urgent scientific scrutiny. While mainstream discourse has largely dismissed these cancers as coincidental or biologically implausible, the mechanistic data presented in this review suggest otherwise. The SARS-CoV-2 spike protein may interfere with core regulatory pathways of carcinogenesis, including metabolic reprogram- ming, immune surveillance, apoptosis resistance, and stem cell proliferation.
It's time for world governments and public health agencies to stop denying reality: COVID-19 mRNA-induced "Turbo Cancers" are real."
https://www.thefocalpoints.com/p/17-ways-mrna-shots-may-cause-cancer
"A comprehensive literature review by Mathilde Debord titled "COVID-19 mRNA vaccines can induce cancer in 17 distinct ways, according to over 100 studies" was just published in Le Point Critique. Drawing from over 100 peer-reviewed studies, it outlines 17 distinct biological mechanisms by which the injections may initiate, accelerate, or reactivate malignant processes.
Below is a summary of the 17 mechanisms identified (the references supporting these statements can be found in the article):
1. Genome Instability
mRNA may be reverse-transcribed and integrated into host DNA, triggering mutations that initiate cancer.
2. Immune Escape
The spike protein binds and inhibits tumor suppressor genes like p53 and BRCA1, shielding cancer cells from immune destruction.
3. Impaired DNA Repair Mechanism
The spike protein interferes with essential DNA repair enzymes, increasing the risk of unchecked mutations.
4. Chronic Inflammation
Lipid nanoparticles and spike protein cause long-lasting inflammation, a well-known driver of cancer.
5. Dysregulation of the Immune System
Suppression of T cells and type I interferon weakens cancer surveillance and promotes immune evasion.
6. RNA Disruption
Codon optimization disrupts microRNA networks, destabilizing cell growth regulation and apoptosis.
7. Activation of Oncogenic Pathways
The spike protein indirectly activates MAPK and PI3K/mTOR signaling, fueling tumor growth and metastasis.
8. Tumor Microenvironment Alteration
Lipid nanoparticles accumulate in tumors, enhancing permeability and potentially accelerating cancer spread.
9. Awakening Dormant Cancers
Post-vaccination inflammation and immune disruption may trigger recurrence in patients previously in remission.
10. Alteration of Immune Surveillance
Modified mRNA blocks toll-like receptors, making tumor cells "invisible" to the immune system.
11. Frameshift Errors
The synthetic mRNA sometimes produces unintended, aberrant proteins, contributing to oncogenic risk.
12. Multiple Injections
Repeated doses exhaust the immune system and drive class switching to IgG4, promoting tolerance to tumors.
13. DNA Contamination
Residual plasmid DNA found in vaccine vials is replication-competent and could integrate into host genomes.
14. Oncogenic SV40 DNA Sequences
SV40 promoter sequences in Pfizer vials may facilitate genome insertion—this same element is used to induce tumors in lab animals.
15. Deregulation of the Renin-Angiotensin System (RAS)
Spike-induced AT1R activation fosters oxidative stress and uncontrolled cell proliferation.
16. Destruction of the Microbiota
The injections deplete bifidobacteria, weakening immune balance and impairing anti-cancer responses.
17. Increased Resistance to Treatments
Spike exposure prolongs cancer cell survival during chemotherapy, possibly driving treatment resistance.
These data help explain the 110,750 excess cancer deaths recorded in the U.S. since the launch of the mass COVID-19 mRNA injection campaign. Analysis of official CDC datasets reveals that excess cancer mortality has not only persisted—but continues to accelerate in 2025."